Biosense Webster receives FDA approval for first catheter ablation therapy in the US to feature direct contact force technology for treatment of Atr

26-02-2014 Business Wire HealthComments (0)

BiotechnologyPharmaceuticalUSA

Biosense Webster, a worldwide leader in the diagnosis and treatment of cardiac arrhythmias, announced today that it has received approval from the United States Food and Drug Administration (FDA) for its THERMOCOOL SMARTTOUCH Catheter. This device is the first therapeutic catheter approved in the U.S. that enables direct and real-time measurement of contact force during catheter ablation procedures for patients suffering from drug-resistant paroxysm

Read more on Business Wire Health

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top